These observations were corroborated by two independent studies, which demonstrated significantly lower mean mRNA levels for PHGDH in IDH-mutated, 1p/19q-deleted gliomas compared to IDH-mutated, non-deleted gliomas [16,17]. The gene discussed is PHGDH; the disease is central nervous system cancer.